FunPep Company Limited

Research FunPep Company Limited (4881.T) on Bullrun: market cap JPY 2.28B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is JPY 2.28B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025JPY 314.00K-JPY 1.91B-JPY 1.39B-412646.8%-50.2JPY 1.77Bn/aJPY 1.46B
FY2024JPY 6.13M-JPY 889.09M-JPY 537.60M-8741.3%-31.98JPY 2.35Bn/aJPY 2.55B
FY2023JPY 530.00K-JPY 933.42M-JPY 989.87M-128356.0%-39.63JPY 1.79Bn/aJPY 2.30B
FY2022JPY 1.07M-JPY 1.17B-JPY 1.07B-85406.6%-61.04JPY 2.25Bn/aJPY 2.69B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18JPY 2.28Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 JPY.

About FunPep Company Limited

FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices in Japan and internationally. The company develops SR-0379, a functional peptide which is in Phase III clinical trial for the treatment of skin ulcer; FPP003, an antibody-inducing peptide which is in Phase II clinical trial for the treatment of psoriasis and ankylosing spondylitis; FPP004X, an antibody-inducing peptide which is in Phase I clinical trial for the treatment of pollinosis;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is FunPep Company Limited's market cap?

FunPep Company Limited's market capitalization is JPY 2.28B.

What does FunPep Company Limited do?

FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices in Japan and internationally.